TAARYZN Trademark

Trademark Overview

On Friday, November 20, 2020, a trademark application was filed for TAARYZN with the United States Patent and Trademark Office. The USPTO has given the TAARYZN trademark a serial number of 90332869. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 9, 2024. This trademark is owned by Sunovion Pharmaceuticals Inc. The TAARYZN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating central nervous system diseases or disorders; pharmaceutical preparations for treating schizophrenia; pharmaceutical preparations for treating cognitive disorders
taaryzn

General Information

Serial Number90332869
Word MarkTAARYZN
Filing DateFriday, November 20, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 8, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for treating central nervous system diseases or disorders; pharmaceutical preparations for treating schizophrenia; pharmaceutical preparations for treating cognitive disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSunovion Pharmaceuticals Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMarlborough, MA 01752
Party NameSunovion Pharmaceuticals Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMarlborough, MA 01752

Trademark Events

Event DateEvent Description
Tuesday, November 24, 2020NEW APPLICATION ENTERED
Thursday, January 7, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, January 7, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 7, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 7, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, January 26, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 7, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 7, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 16, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 16, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 16, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 16, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, March 16, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 16, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, May 4, 2021ASSIGNED TO EXAMINER
Wednesday, May 5, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 19, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 8, 2021PUBLISHED FOR OPPOSITION
Tuesday, June 8, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 3, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sunday, January 30, 2022SOU TEAS EXTENSION RECEIVED
Sunday, January 30, 2022SOU EXTENSION 1 FILED
Sunday, January 30, 2022SOU EXTENSION 1 GRANTED
Tuesday, February 1, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 24, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 24, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 24, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 7, 2022SOU TEAS EXTENSION RECEIVED
Thursday, July 7, 2022SOU EXTENSION 2 FILED
Thursday, July 7, 2022SOU EXTENSION 2 GRANTED
Saturday, July 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 6, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, December 6, 2022SOU EXTENSION 3 FILED
Tuesday, December 6, 2022SOU EXTENSION 3 GRANTED
Thursday, December 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 23, 2023SOU TEAS EXTENSION RECEIVED
Friday, June 23, 2023SOU EXTENSION 4 FILED
Friday, June 23, 2023SOU EXTENSION 4 GRANTED
Tuesday, June 27, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 11, 2024SOU TEAS EXTENSION RECEIVED
Thursday, January 11, 2024SOU EXTENSION 5 FILED
Monday, January 29, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, January 29, 2024SOU EXTENSION 5 GRANTED
Tuesday, January 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 9, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, September 9, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

taaryzn pharmaceutical treating preparations disorders schizophrenia cognitive nervous central system diseases